227 related articles for article (PubMed ID: 36034756)
1. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
Zhang X; Tian C; Cheng J; Mao W; Li M; Chen M
Exp Ther Med; 2022 Sep; 24(3):563. PubMed ID: 36034756
[TBL] [Abstract][Full Text] [Related]
2. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
[TBL] [Abstract][Full Text] [Related]
3. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
4. Identification of Immune Infiltration and the Potential Biomarkers in Diabetic Peripheral Neuropathy through Bioinformatics and Machine Learning Methods.
Li W; Guo J; Chen J; Yao H; Mao R; Li C; Zhang G; Chen Z; Xu X; Wang C
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671424
[TBL] [Abstract][Full Text] [Related]
5. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
6. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L
Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835
[No Abstract] [Full Text] [Related]
7. The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.
Song Z; Huang Y; Zhao Y; Ruan H; Yang H; Cao Q; Liu D; Zhang X; Chen K
J Cancer; 2019; 10(6):1398-1408. PubMed ID: 31031850
[No Abstract] [Full Text] [Related]
8. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
PeerJ; 2023; 11():e15013. PubMed ID: 37070095
[TBL] [Abstract][Full Text] [Related]
10. Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis.
Liang X; Wang Y; Pei L; Tan X; Dong C
Front Surg; 2022; 9():856446. PubMed ID: 35372462
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of immune-related hub genes based on machine learning in prostate cancer and AOX1 is an oxidative stress-related biomarker.
Mo X; Yuan K; Hu D; Huang C; Luo J; Liu H; Li Y
Front Oncol; 2023; 13():1179212. PubMed ID: 37583929
[TBL] [Abstract][Full Text] [Related]
12. Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.
Yu Z; Chao H; Xu F; Deng H; Deng L; Song Z; Zeng T
Front Oncol; 2023; 13():1115718. PubMed ID: 37077837
[TBL] [Abstract][Full Text] [Related]
13. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
Jin D; Yuan L; Li F; Wang S; Mao Y
BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
[TBL] [Abstract][Full Text] [Related]
14. Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway.
Liu F; Liang Y; Sun R; Yang W; Liang Z; Gu J; Zhao F; Tang D
Chin Med; 2022 Aug; 17(1):91. PubMed ID: 35922850
[TBL] [Abstract][Full Text] [Related]
15. High expression of TREM2 promotes EMT via the PI3K/AKT pathway in gastric cancer: bioinformatics analysis and experimental verification.
Li C; Hou X; Yuan S; Zhang Y; Yuan W; Liu X; Li J; Wang Y; Guan Q; Zhou Y
J Cancer; 2021; 12(11):3277-3290. PubMed ID: 33976737
[No Abstract] [Full Text] [Related]
16. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
17. Identification of cell differentiation trajectory-related gene signature to reveal the prognostic significance and immune landscape in prostate cancer based on multiomics analysis.
Sun L; Tuo Z; Chen X; Wang H; Lyu Z; Li G
Heliyon; 2024 Mar; 10(6):e27628. PubMed ID: 38510027
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
19. The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment.
Sun JX; An Y; Xiang JC; Xu JZ; Hu J; Wang SG; Xia QD
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686409
[TBL] [Abstract][Full Text] [Related]
20. A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer.
Feng D; Shi X; You J; Xiong Q; Zhu W; Wei Q; Yang L
Am J Cancer Res; 2022; 12(8):3811-3828. PubMed ID: 36119834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]